Holocarboxylase synthetase deficiency

Holocarboxylase synthetase deficiency
OMIM	253270
DiseasesDB	32709
eMedicine	ped/1020
MeSH	D028922

WikiDoc Resources for Holocarboxylase synthetase deficiency
Articles
Most recent articles on Holocarboxylase synthetase deficiency Most cited articles on Holocarboxylase synthetase deficiency Review articles on Holocarboxylase synthetase deficiency Articles on Holocarboxylase synthetase deficiency in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Holocarboxylase synthetase deficiency Images of Holocarboxylase synthetase deficiency Photos of Holocarboxylase synthetase deficiency Podcasts & MP3s on Holocarboxylase synthetase deficiency Videos on Holocarboxylase synthetase deficiency
Evidence Based Medicine
Cochrane Collaboration on Holocarboxylase synthetase deficiency Bandolier on Holocarboxylase synthetase deficiency TRIP on Holocarboxylase synthetase deficiency
Clinical Trials
Ongoing Trials on Holocarboxylase synthetase deficiency at Clinical Trials.gov Trial results on Holocarboxylase synthetase deficiency Clinical Trials on Holocarboxylase synthetase deficiency at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Holocarboxylase synthetase deficiency NICE Guidance on Holocarboxylase synthetase deficiency NHS PRODIGY Guidance FDA on Holocarboxylase synthetase deficiency CDC on Holocarboxylase synthetase deficiency
Books
Books on Holocarboxylase synthetase deficiency
News
Holocarboxylase synthetase deficiency in the news Be alerted to news on Holocarboxylase synthetase deficiency News trends on Holocarboxylase synthetase deficiency
Commentary
Blogs on Holocarboxylase synthetase deficiency
Definitions
Definitions of Holocarboxylase synthetase deficiency
Patient Resources / Community
Patient resources on Holocarboxylase synthetase deficiency Discussion groups on Holocarboxylase synthetase deficiency Patient Handouts on Holocarboxylase synthetase deficiency Directions to Hospitals Treating Holocarboxylase synthetase deficiency Risk calculators and risk factors for Holocarboxylase synthetase deficiency
Healthcare Provider Resources
Symptoms of Holocarboxylase synthetase deficiency Causes & Risk Factors for Holocarboxylase synthetase deficiency Diagnostic studies for Holocarboxylase synthetase deficiency Treatment of Holocarboxylase synthetase deficiency
Continuing Medical Education (CME)
CME Programs on Holocarboxylase synthetase deficiency
International
Holocarboxylase synthetase deficiency en Espanol Holocarboxylase synthetase deficiency en Francais
Business
Holocarboxylase synthetase deficiency in the Marketplace Patents on Holocarboxylase synthetase deficiency
Experimental / Informatics
List of terms related to Holocarboxylase synthetase deficiency

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Holocarboxylase synthetase deficiency is an inherited disorder in which the body is unable to use the vitamin biotin effectively. This disorder is classified as a multiple carboxylase deficiency, a group of disorders characterized by impaired activity of certain enzymes that depend on biotin. The signs and symptoms of holocarboxylase synthetase deficiency typically appear within the first few months of life, but the age of onset varies. Affected infants often have immunodeficiency diseases, difficulty feeding, breathing problems, a skin rash, hair loss (alopecia), and a lack of energy (lethargy). Immediate treatment and lifelong management (using biotin supplements) may prevent many of these complications. If left untreated, the disorder can lead to delayed development, seizures, and coma. These medical problems may be life-threatening in some cases.

This condition is inherited in an autosomal recessive pattern, which means two copies of the gene in each cell are altered.

Mutations in the HLCS gene cause holocarboxylase synthetase deficiency. The HLCS gene makes an enzyme, holocarboxylase synthetase, that attaches biotin to other molecules. Biotin, a B vitamin, is found in foods such as liver, egg yolks, and milk. It is essential for the normal production and breakdown of proteins, fats, and carbohydrates in the body. Mutations in the HLCS gene reduce the activity of holocarboxylase synthetase, preventing cells from using biotin effectively and disrupting many cellular functions. These defects lead to the serious medical problems associated with holocarboxylase deficiency.

This article incorporates public domain text from The U.S. National Library of Medicine